Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Marie Desiles S. Komenan"'
Autor:
Antoni Ribas, Beata Berent-Maoz, Paula J. Kaplan-Lefko, Paula Cabrera, Xiaoyan Wang, Donald B. Kohn, Begonya Comin-Anduix, David Baltimore, Owen N. Witte, Lili Yang, Alexander Nguyen, Celia Adelson, Eric H. Gschweng, Kenneth Cornetta, Daniela Bischof, Beatriz Campo-Fernandez, Roger P. Hollis, Gay M. Crooks, Amelie Montel-Hagen, Christopher S. Seet, Brad Bolon, Jeffrey L. Goodwin, Justin D. Saco, Mignonette H. Macabali, Jia Pang, Marie Desiles S. Komenan, Agustin Vega-Crespo, Nhat A. Truong, Gardenia C. Cheung-Lau, James McCabe, Ameya S. Champhekar, Ruixue Zhang, Salemiz Sandoval, Paige E. Krystofinski, Angel Garcia-Diaz, Giulia Parisi, Cristina Puig-Saus
Supplemental Figure 1: Hypothetical model of peripheral blood TCR-transgenic cell repopulation. Supplemental Figure 2: GLP team organizational chart. Supplemental Figure 3. Bone marrow transplant (BMT) optimization studies in HLA-A2/Kb transgenic mic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a236dda1faa85487df2772f809b017e3
https://doi.org/10.1158/1078-0432.22468605.v1
https://doi.org/10.1158/1078-0432.22468605.v1
Autor:
Antoni Ribas, Beata Berent-Maoz, Paula J. Kaplan-Lefko, Paula Cabrera, Xiaoyan Wang, Donald B. Kohn, Begonya Comin-Anduix, David Baltimore, Owen N. Witte, Lili Yang, Alexander Nguyen, Celia Adelson, Eric H. Gschweng, Kenneth Cornetta, Daniela Bischof, Beatriz Campo-Fernandez, Roger P. Hollis, Gay M. Crooks, Amelie Montel-Hagen, Christopher S. Seet, Brad Bolon, Jeffrey L. Goodwin, Justin D. Saco, Mignonette H. Macabali, Jia Pang, Marie Desiles S. Komenan, Agustin Vega-Crespo, Nhat A. Truong, Gardenia C. Cheung-Lau, James McCabe, Ameya S. Champhekar, Ruixue Zhang, Salemiz Sandoval, Paige E. Krystofinski, Angel Garcia-Diaz, Giulia Parisi, Cristina Puig-Saus
Purpose:To improve persistence of adoptively transferred T-cell receptor (TCR)–engineered T cells and durable clinical responses, we designed a clinical trial to transplant genetically-modified hematopoietic stem cells (HSCs) together with adoptive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0977b77b6344a53461ba7d218f922c66
https://doi.org/10.1158/1078-0432.c.6527007.v1
https://doi.org/10.1158/1078-0432.c.6527007.v1
Autor:
Cristina Puig-Saus, Giulia Parisi, Angel Garcia-Diaz, Paige E. Krystofinski, Salemiz Sandoval, Ruixue Zhang, Ameya S. Champhekar, James McCabe, Gardenia C. Cheung-Lau, Nhat A. Truong, Agustin Vega-Crespo, Marie Desiles S. Komenan, Jia Pang, Mignonette H. Macabali, Justin D. Saco, Jeffrey L. Goodwin, Brad Bolon, Christopher S. Seet, Amelie Montel-Hagen, Gay M. Crooks, Roger P. Hollis, Beatriz Campo-Fernandez, Daniela Bischof, Kenneth Cornetta, Eric H. Gschweng, Celia Adelson, Alexander Nguyen, Lili Yang, Owen N. Witte, David Baltimore, Begonya Comin-Anduix, Donald B. Kohn, Xiaoyan Wang, Paula Cabrera, Paula J. Kaplan-Lefko, Beata Berent-Maoz, Antoni Ribas
Publikováno v:
Puig-Saus, C; Parisi, G; Garcia-Diaz, A; Krystofinski, PE; Sandoval, S; Zhang, R; et al.(2018). IND-enabling studies for a clinical trial to genetically program a persistent cancer-targeted immune system.. Clinical cancer research : an official journal of the American Association for Cancer Research. doi: 10.1158/1078-0432.ccr-18-0963. UCLA: Retrieved from: http://www.escholarship.org/uc/item/0kr4v73j
Clinical cancer research : an official journal of the American Association for Cancer Research, vol 25, iss 3
Clinical cancer research : an official journal of the American Association for Cancer Research, vol 25, iss 3
Purpose: To improve persistence of adoptively transferred T-cell receptor (TCR)–engineered T cells and durable clinical responses, we designed a clinical trial to transplant genetically-modified hematopoietic stem cells (HSCs) together with adoptiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27257f6eef658bcbc8324cdeb39925dc
http://www.escholarship.org/uc/item/0kr4v73j
http://www.escholarship.org/uc/item/0kr4v73j
Autor:
Roger S. Lo, Jesse M. Zaretsky, Daniel Shin, Begonya Comin-Anduix, Grace Cherry, Willy Hugo, Beata Berent-Maoz, Marie Desiles S. Komenan, Antoni Ribas, Siwen Hu-Lieskovan, Helena Escuin-Ordinas, Bartosz Chmielowski, Nicolaos Palaskas, Angel Garcia-Diaz, Thomas G. Graeber
Publikováno v:
Journal for Immunotherapy of Cancer
Meeting abstracts PD-L1-negative tumors assessed by immunohistochemistry often still respond to PD-1 blockade. PD-L1 is inducible by interferon, therefore, absolute negative tumors are the ones unable to up-regulate PD-L1 in response to interferons.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9113b7649ed21897e172d3fcc36fe104
https://doi.org/10.1186/2051-1426-3-s2-p311
https://doi.org/10.1186/2051-1426-3-s2-p311
